Medical Device Makers Drive Australia’s Biotech Sector Gains
This article was originally published in PharmAsia News
Executive Summary
The medical device sector of Australia's biotech industry is the most successful sector, as demonstrated by AtCor Medical's report of a 76 percent increase in interim sales. The company said its sales increase was driven in a large part by its SphygmoCor devices for measuring blood pressure. The report belies the economic slowdown Australia is experiencing along with the rest of the world. U.S. sales alone accounted for a125 percent increase in the company's sales as pharmaceutical companies sought central blood-pressure measurements for clinical trials. (Click here for more